August Moretti
Mr. Moretti has extensive operating and financial executive experience in all phases of company growth and funding, from early-stage development to product approval and commercialization. Mr. Moretti is currently self-employed as a consultant, but previously served as the Chief Financial Officer of 4D Molecular Therapeutics, Inc., Assertio Therapeutics (formerly Depomed, Inc.), Alexza Pharmaceuticals, Inc., and as Chief Financial Officer and General Counsel of Alavita, Inc.
Earlier in his career, Mr. Moretti was a partner in an international law firm, where his practice included representation of life science companies on issues relating to public and private financings, mergers and acquisitions, corporate governance, disclosure and public reporting.
Mr. Moretti received his B.A. in Economics from Princeton University in 1972. He received his J.D. from Harvard Law School in 1975.